Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Options Exercise Instructions
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

ASX Announcements 2010

  • 24 Dec 2010

    Options

  • 23 Dec 2010

    Biotron Limited Security Trading Policy

  • 26 Nov 2010

    Results of Annual General Meeting

  • 25 Nov 2010

    International Study Supports Biotron’s HIV Drug Approach

  • 11 Nov 2010

    Presentation to investors

  • 27 Oct 2010

    Quarterly Report 30 September 2010

  • 27 Oct 2010

    Annual Report for year ended 30 June 2010 and Notice of Annual General Meeting

  • 20 Oct 2010

    Presentation to investors

  • 14 Oct 2010

    October 2010 edition of BITNews

  • 1 Oct 2010

    Phase II HCV Clinical Trial Commenced

  • 31 Aug 2010

    Year End Accounts and Preliminary Final Report for year ended 30 June 2010

  • 11 Aug 2010

    Quarterly Report 30 June 2010

  • 23 Jul 2010

    Presentation at International AIDS Conference

  • 30 Jun 2010

    June 2010 edition of BITNews

  • 25 May 2010

    Issue of Shares

  • 19 May 2010

    Change of Director’s Interest Notice

  • 30 Apr 2010

    Appointment of a Director

  • 22 Apr 2010

    Quarterly Report 31 March 2010

  • 1 Apr 2010

    Director Resignation

  • 19 Mar 2010

    Shareholder Update and Piggy Back Options Opportunity

  • 18 Mar 2010

    Biotron HCV Drug: International Partner to Progress Trial

  • 26 Feb 2010

    Half-year report 31 December 2009

  • 5 Feb 2010

    Allotment and Distribution of New Options

  • 27 Jan 2010

    Quarterly Report 31 December 2009

  • 22 Jan 2010

    Change of Director’s Interest Notice

  • 15 Jan 2010

    Entitlement Issue 23% Oversubscribed

  • <<
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • >>

Investor Centre

  • Investor Centre
    • ASX Announcements
    • Annual reports
    • Corporate Directory
    • Shareholder services
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 30 May 2022        Legal Notices and Privacy